Clinical potential of psilocybin as a treatment for mental health conditions

Daniel, J., & Haberman, M. | Mental Health Clinician | 1 January 2017

Conducting PTSD clinical trials on a Schedule I drug: MDMA

Knopf, A. | Alcoholism & Drug Abuse Weekly | 12 December 2016

Psilocybin: promising results in double-blind trials require confirmation by real-world evidence

Breckenridge, A., & Grobbee, D. E. | Journal of psychopharmacology | 6 December 2016

Psilocybin-assisted psychotherapy for dying cancer patients – aiding the final trip

Spiegel, D. | Journal of psychopharmacology | 6 December 2016

Psilocybin for depression and anxiety associated with life-threatening illnesses

McCorvy, J. D., Olsen, R. H., & Roth, B. L. | Journal of psychopharmacology | 6 December 2016

The role of psychedelics in palliative care reconsidered: A case for psilocybin

Kelmendi, B., Corlett, P., Ranganathan, M., D'Souza, C., & Krystal, J. H. | Journal of psychopharmacology | 1 December 2016

Psilocybin and palliative end-of-life care

Shelton, R. C., & Hendricks, P. S. | Journal of Psychopharmacology | 1 December 2016

Psilocybin in end of life care: Implications for further research

Summergrad, P. | Journal of Psychopharmacology | 1 December 2016

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., ... & Klinedinst, M. A. | Journal of Psychopharmacology | 1 December 2016

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., ... & Su, Z. | Journal of Psychopharmacology | 1 December 2016

Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future

Nutt, D. | Journal of Psychopharmacology | 1 December 2016

The Therapeutic Potential of Ayahuasca

Coe, M. A., & McKenna, D. J. | Springer International Publishing | 1 December 2016

Potential Psychiatric Uses for MDMA

Klosinski, B. B., & Mithoefer, M. C. | Clinical Pharmacology & Therapeutics | 9 November 2016

Psychedelics as Medicines: An emerging new paradigm

Nichols, D. E., Johnson, M. W., & Nichols, C. D. | Clinical Pharmacology & Therapeutics | 4 November 2016

Investigation of Personality Change Following MDMA-Assisted Psychotherapy for Post Traumatic Stress Disorder

Wagner, M., Mithoefer, M., Mithoefer, A., MacAulay, R., Jerome, L., Bazaar-Klosinski, B., & Doblin, R. | Archives of Clinical Neuropsychology | 1 August 2016

MDMA and PTSD treatment: “PTSD: From novel pathophysiology to innovative therapeutics”

Sessa, B. | Neuroscience Letters | 6 July 2016

±3,4-Methylenedioxymethamphetamine: Treating PTSD in The Modern World

Baxter, A. | Academic Excellence Showcase Schedule | 26 May 2016

Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: A preliminary meta-analysis and comparison to prolonged exposure therapy

Amoroso, T., & Workman, M. | Journal of psychopharmacology | 26 April 2016

Anxiety Mescaline

Kyzar, E. J., Collins, C., Gaikwad, S., Green, J., Roth, A., Monnig, L., ... & Stewart, A. M.

Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA

Mithoefer, M. C., Grob, C. S., & Brewerton, T. D. | The Lancet Psychiatry | 5 April 2016

Race-Based Trauma: The Challenge and Promise of MDMA-Assisted Psychotherapy

Williams, M. T. | MAPS Bulletin | 1 April 2016

Can ecstasy treat the agony of PTSD?

Mithoefer, M. | European Psychiatry | 1 April 2016

Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies

dos Santos, R. G., Osório, F. L., Crippa, J. A. S., & Hallak, J. E. | Revista Brasileira de Psiquiatria | 24 March 2016

Lysergic acid diethylamide: a drug of ‘use’?

Das, S., Barnwal, P., Ramasamy, A., Sen, S., & Mondal, S. | Therapeutic Advances in Psychopharmacology | 23 March 2016

Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years

dos Santos, R. G., Osório, F. L., Crippa, J. A. S., Riba, J., Zuardi, A. W., & Hallak, J. E. | Therapeutic Advances in Psychopharmacology | 18 March 2016